Hereditary Angioedema Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251339 | Category: Pharma & Healthcare | Pages: 78 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.
This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema. This report contains market size and forecasts of Hereditary Angioedema in global, including the following market information:
Global Hereditary Angioedema Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hereditary Angioedema Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hereditary Angioedema companies in 2022 (%)
The global Hereditary Angioedema market was valued at US$ 1704.7 million in 2022 and is projected to reach US$ 2731.4 million by 2029, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
C1 Esterase Inhibitor Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hereditary Angioedema include Pharming Group NV, Takeda, CSL Limited, iBio Inc., BioCryst Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hereditary Angioedema manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Angioedema Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hereditary Angioedema Market Segment Percentages, by Type, 2022 (%)
    C1 Esterase Inhibitor
    Kallikrein Inhibitor
    Selective Bradykinin B2 Receptor Antagonist
Global Hereditary Angioedema Market, by Distribution Channel, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hereditary Angioedema Market Segment Percentages, by Distribution Channel, 2022 (%)
    Retail Pharmacies
    Hospital Pharmacies
    Online Pharmacies
Global Hereditary Angioedema Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hereditary Angioedema Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hereditary Angioedema revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hereditary Angioedema revenues share in global market, 2022 (%)
Key companies Hereditary Angioedema sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hereditary Angioedema sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Pharming Group NV
    Takeda
    CSL Limited
    iBio Inc.
    BioCryst Pharmaceuticals, Inc.
    Ionis Pharmaceuticals, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hereditary Angioedema, market overview.
Chapter 2: Global Hereditary Angioedema market size in revenue and volume.
Chapter 3: Detailed analysis of Hereditary Angioedema manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hereditary Angioedema in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hereditary Angioedema capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Hereditary Angioedema Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Distribution Channel
    1.3 Global Hereditary Angioedema Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hereditary Angioedema Overall Market Size
    2.1 Global Hereditary Angioedema Market Size: 2022 VS 2029
    2.2 Global Hereditary Angioedema Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Hereditary Angioedema Sales: 2018-2029
3 Company Landscape
    3.1 Top Hereditary Angioedema Players in Global Market
    3.2 Top Global Hereditary Angioedema Companies Ranked by Revenue
    3.3 Global Hereditary Angioedema Revenue by Companies
    3.4 Global Hereditary Angioedema Sales by Companies
    3.5 Global Hereditary Angioedema Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Hereditary Angioedema Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Hereditary Angioedema Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Hereditary Angioedema Players in Global Market
        3.8.1 List of Global Tier 1 Hereditary Angioedema Companies
        3.8.2 List of Global Tier 2 and Tier 3 Hereditary Angioedema Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Hereditary Angioedema Market Size Markets, 2022 & 2029
        4.1.2 C1 Esterase Inhibitor
        4.1.3 Kallikrein Inhibitor
        4.1.4 Selective Bradykinin B2 Receptor Antagonist
    4.2 By Type - Global Hereditary Angioedema Revenue & Forecasts
        4.2.1 By Type - Global Hereditary Angioedema Revenue, 2018-2023
        4.2.2 By Type - Global Hereditary Angioedema Revenue, 2024-2029
        4.2.3 By Type - Global Hereditary Angioedema Revenue Market Share, 2018-2029
    4.3 By Type - Global Hereditary Angioedema Sales & Forecasts
        4.3.1 By Type - Global Hereditary Angioedema Sales, 2018-2023
        4.3.2 By Type - Global Hereditary Angioedema Sales, 2024-2029
        4.3.3 By Type - Global Hereditary Angioedema Sales Market Share, 2018-2029
    4.4 By Type - Global Hereditary Angioedema Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Distribution Channel
    5.1 Overview
        5.1.1 By Distribution Channel - Global Hereditary Angioedema Market Size, 2022 & 2029
        5.1.2 Retail Pharmacies
        5.1.3 Hospital Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Distribution Channel - Global Hereditary Angioedema Revenue & Forecasts
        5.2.1 By Distribution Channel - Global Hereditary Angioedema Revenue, 2018-2023
        5.2.2 By Distribution Channel - Global Hereditary Angioedema Revenue, 2024-2029
        5.2.3 By Distribution Channel - Global Hereditary Angioedema Revenue Market Share, 2018-2029
    5.3 By Distribution Channel - Global Hereditary Angioedema Sales & Forecasts
        5.3.1 By Distribution Channel - Global Hereditary Angioedema Sales, 2018-2023
        5.3.2 By Distribution Channel - Global Hereditary Angioedema Sales, 2024-2029
        5.3.3 By Distribution Channel - Global Hereditary Angioedema Sales Market Share, 2018-2029
    5.4 By Distribution Channel - Global Hereditary Angioedema Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Hereditary Angioedema Market Size, 2022 & 2029
    6.2 By Region - Global Hereditary Angioedema Revenue & Forecasts
        6.2.1 By Region - Global Hereditary Angioedema Revenue, 2018-2023
        6.2.2 By Region - Global Hereditary Angioedema Revenue, 2024-2029
        6.2.3 By Region - Global Hereditary Angioedema Revenue Market Share, 2018-2029
    6.3 By Region - Global Hereditary Angioedema Sales & Forecasts
        6.3.1 By Region - Global Hereditary Angioedema Sales, 2018-2023
        6.3.2 By Region - Global Hereditary Angioedema Sales, 2024-2029
        6.3.3 By Region - Global Hereditary Angioedema Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Hereditary Angioedema Revenue, 2018-2029
        6.4.2 By Country - North America Hereditary Angioedema Sales, 2018-2029
        6.4.3 US Hereditary Angioedema Market Size, 2018-2029
        6.4.4 Canada Hereditary Angioedema Market Size, 2018-2029
        6.4.5 Mexico Hereditary Angioedema Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Hereditary Angioedema Revenue, 2018-2029
        6.5.2 By Country - Europe Hereditary Angioedema Sales, 2018-2029
        6.5.3 Germany Hereditary Angioedema Market Size, 2018-2029
        6.5.4 France Hereditary Angioedema Market Size, 2018-2029
        6.5.5 U.K. Hereditary Angioedema Market Size, 2018-2029
        6.5.6 Italy Hereditary Angioedema Market Size, 2018-2029
        6.5.7 Russia Hereditary Angioedema Market Size, 2018-2029
        6.5.8 Nordic Countries Hereditary Angioedema Market Size, 2018-2029
        6.5.9 Benelux Hereditary Angioedema Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Hereditary Angioedema Revenue, 2018-2029
        6.6.2 By Region - Asia Hereditary Angioedema Sales, 2018-2029
        6.6.3 China Hereditary Angioedema Market Size, 2018-2029
        6.6.4 Japan Hereditary Angioedema Market Size, 2018-2029
        6.6.5 South Korea Hereditary Angioedema Market Size, 2018-2029
        6.6.6 Southeast Asia Hereditary Angioedema Market Size, 2018-2029
        6.6.7 India Hereditary Angioedema Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Hereditary Angioedema Revenue, 2018-2029
        6.7.2 By Country - South America Hereditary Angioedema Sales, 2018-2029
        6.7.3 Brazil Hereditary Angioedema Market Size, 2018-2029
        6.7.4 Argentina Hereditary Angioedema Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Hereditary Angioedema Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Hereditary Angioedema Sales, 2018-2029
        6.8.3 Turkey Hereditary Angioedema Market Size, 2018-2029
        6.8.4 Israel Hereditary Angioedema Market Size, 2018-2029
        6.8.5 Saudi Arabia Hereditary Angioedema Market Size, 2018-2029
        6.8.6 UAE Hereditary Angioedema Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Pharming Group NV
        7.1.1 Pharming Group NV Company Summary
        7.1.2 Pharming Group NV Business Overview
        7.1.3 Pharming Group NV Hereditary Angioedema Major Product Offerings
        7.1.4 Pharming Group NV Hereditary Angioedema Sales and Revenue in Global (2018-2023)
        7.1.5 Pharming Group NV Key News & Latest Developments
    7.2 Takeda
        7.2.1 Takeda Company Summary
        7.2.2 Takeda Business Overview
        7.2.3 Takeda Hereditary Angioedema Major Product Offerings
        7.2.4 Takeda Hereditary Angioedema Sales and Revenue in Global (2018-2023)
        7.2.5 Takeda Key News & Latest Developments
    7.3 CSL Limited
        7.3.1 CSL Limited Company Summary
        7.3.2 CSL Limited Business Overview
        7.3.3 CSL Limited Hereditary Angioedema Major Product Offerings
        7.3.4 CSL Limited Hereditary Angioedema Sales and Revenue in Global (2018-2023)
        7.3.5 CSL Limited Key News & Latest Developments
    7.4 iBio Inc.
        7.4.1 iBio Inc. Company Summary
        7.4.2 iBio Inc. Business Overview
        7.4.3 iBio Inc. Hereditary Angioedema Major Product Offerings
        7.4.4 iBio Inc. Hereditary Angioedema Sales and Revenue in Global (2018-2023)
        7.4.5 iBio Inc. Key News & Latest Developments
    7.5 BioCryst Pharmaceuticals, Inc.
        7.5.1 BioCryst Pharmaceuticals, Inc. Company Summary
        7.5.2 BioCryst Pharmaceuticals, Inc. Business Overview
        7.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Major Product Offerings
        7.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales and Revenue in Global (2018-2023)
        7.5.5 BioCryst Pharmaceuticals, Inc. Key News & Latest Developments
    7.6 Ionis Pharmaceuticals, Inc.
        7.6.1 Ionis Pharmaceuticals, Inc. Company Summary
        7.6.2 Ionis Pharmaceuticals, Inc. Business Overview
        7.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Major Product Offerings
        7.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales and Revenue in Global (2018-2023)
        7.6.5 Ionis Pharmaceuticals, Inc. Key News & Latest Developments
8 Global Hereditary Angioedema Production Capacity, Analysis
    8.1 Global Hereditary Angioedema Production Capacity, 2018-2029
    8.2 Hereditary Angioedema Production Capacity of Key Manufacturers in Global Market
    8.3 Global Hereditary Angioedema Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Hereditary Angioedema Supply Chain Analysis
    10.1 Hereditary Angioedema Industry Value Chain
    10.2 Hereditary Angioedema Upstream Market
    10.3 Hereditary Angioedema Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Hereditary Angioedema Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Hereditary Angioedema Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?